Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial-Reference-Cited by-同舟云学术

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Published:2016-01 Issue:10013 Volume:387 Page:40-52
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Thaçi Diamant,Simpson Eric L,Beck Lisa A,Bieber Thomas,Blauvelt Andrew,Papp Kim,Soong Weily,Worm Margitta,Szepietowski Jacek C,Sofen Howard,Kawashima Makoto,Wu Richard,Weinstein Steven P,Graham Neil M H,Pirozzi Gianluca,Teper Ariel,Sutherland E Rand,Mastey Vera,Stahl Neil,Yancopoulos George D,Ardeleanu Marius

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Guidelines of care for the management of atopic dermatitis. Section 1. Diagnosis and assessment of atopic dermatitis;Eichenfield;J Am Acad Dermatol,2014

2. Guidelines for treatment of atopic eczema (atopic dermatitis) Part 1;Ring;J Eur Acad Dermatol Venereol,2012

3. Guidelines of care for the management of atopic dermatitis. Section 2. Management and treatment of atopic dermatitis with topical therapies;Eichenfield;J Am Acad Dermatol,2014

4. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II;Ring;J Eur Acad Dermatol Venereol,2012

5. Guidelines of care for the management of atopic dermatitis. Section 3. Management and treatment with phototherapy and systemic agents;Sidbury;J Am Acad Dermatol,2014

Cited by 485 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Therapies in Outpatient Pulmonary Medicine;Medical Clinics of North America;2024-09

2. Exploring novel drug targets for atopic dermatitis through plasma proteome with genome;Archives of Dermatological Research;2024-08-13

3. Cendakimab in Patients With Moderate to Severe Atopic Dermatitis;JAMA Dermatology;2024-08-01

4. Dupilumab in Adults With Moderate to Severe Atopic Dermatitis;JAMA Dermatology;2024-08-01

5. Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials;Clinical and Translational Science;2024-07-30